Nomura Holdings’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.09M Hold
200,000
﹤0.01% 1126
2025
Q4
$1.4M Hold
200,000
﹤0.01% 1224
2025
Q3
$1.55M Hold
200,000
﹤0.01% 1243
2025
Q2
$1.74M Sell
200,000
-150,000
-43% -$1.09M ﹤0.01% 865
2025
Q1
$2.79M Buy
+350,000
New +$3.54M 0.01% 920
2024
Q3
Sell
-48,600
Closed -$475K 1972
2024
Q2
$475K Buy
+48,600
New +$593K ﹤0.01% 1338
2022
Q2
Sell
-13,100
Closed -$966K 2146
2022
Q1
$966K Sell
13,100
-8,900
-40% -$641K ﹤0.01% 1131
2021
Q4
$2.02M Buy
+22,000
New +$2.63M 0.01% 994
2021
Q3
Sell
-17,400
Closed -$2.9M 2207
2021
Q2
$2.9M Sell
17,400
-49,400
-74% -$8M 0.01% 746
2021
Q1
$12.2M Buy
+66,800
New +$15.5M 0.03% 296
2019
Q4
Sell
-196,200
Closed -$13.1M 1334
2019
Q3
$13.1M Buy
+196,200
New +$12.9M 0.05% 270

Other funds holding TDOC

Nomura Holdings's TDOC Position: Q1 2026 in Review

Nomura Holdings increased its Teladoc Health (TDOC) stake by 30% in Q1 2026, buying an estimated $58.2K and bringing the position to 45,477 shares worth $248K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

Nomura Holdings first reported a position in TDOC in Q2 2016 and has held it in 25 quarters since. The position peaked at $9.37M in Q4 2021. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Nomura Holdings held 45,477 shares of Teladoc Health worth $248K as of Q1 2026.
  • Nomura Holdings bought 10,370 Teladoc Health shares in Q1 2026, an estimated $58.2K.
  • Teladoc Health made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1528 holding.
  • Nomura Holdings first reported a position in Teladoc Health in Q2 2016 and has held it in 25 quarters since.
  • Nomura Holdings's Teladoc Health position peaked at $9.37M in Q4 2021.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.